Furthermore, in vitro studies revealed that treatment with chemerin induces insulin resistance in human skeletal muscle cells at the levels of IRS1 (Insulin receptor substrate 1), protein kinases B (PKB), and Glycogen synthase kinase 3 (GSK3) phosphorrylation and glucose uptake[11]. The gene discussed is IRS1; the disease is Insulin resistance.